Persica Pharma announces positive phase 1b Modic trial of PP353, a novel, non-opioid intradiscal injection to treat chronic low back pain: London, UK Thursday, March 6, 2025, 18:0 ...

SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through ...

Evidence has shown that 25% of patients with chronic lower back pain could be suffering from an infection in the disc space.

Topline Results for Phase 2b PROGRESS Study of Pilavapadin (LX9211) in Diabetic Peripheral Neuropathic Pain (DPNP); 10 mg dose to Advance into ...

Tris Pharma’s first-in-class oral dual-NMR agonist achieved its primary endpoint in the ALLEVIATE-2 study by demonstrating a ...

Positive data from a pair of acute pain studies convinced the company that its drug, which works differently than existing ...

A research team has developed a non-opioid medication that shows promise in treating acute and chronic pain. The drug, known ...

Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company, today announced positive topline results from its ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Neumora Therapeutics (NASDAQ:NMRA – Get Free Report)‘s stock had its “sector perform” rating reaffirmed by investment ...

Amanda Seyfried put on a dazzling display in an eye-catching ensemble at the NYC premiere of her upcoming crime drama Long Bright River on Wednesday.

From beloved classics to recent releases, a myriad of books are set to be reimagined for the small and big screens.